• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 3. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives 2-phenylindoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indoles 2-phenylindoles

Research Brief on 3-Bromo-1-methyl-2-phenyl-1H-indole (CAS: 609844-40-8): Recent Advances and Applications

3-Bromo-1-methyl-2-phenyl-1H-indole (CAS: 609844-40-8) is a brominated indole derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and medicinal chemistry. Recent studies have explored its potential as a key intermediate in the synthesis of bioactive compounds, particularly in the development of kinase inhibitors and anti-inflammatory agents. This research brief aims to summarize the latest findings related to this compound, highlighting its synthetic utility, biological activities, and potential therapeutic applications.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the role of 3-Bromo-1-methyl-2-phenyl-1H-indole as a precursor in the synthesis of novel indole-based kinase inhibitors. The study demonstrated that the bromine atom at the 3-position of the indole ring serves as a critical handle for further functionalization via cross-coupling reactions, enabling the rapid generation of diverse compound libraries. The resulting derivatives exhibited potent inhibitory activity against a range of kinases, including JAK2 and FLT3, which are implicated in various cancers and inflammatory diseases.

Another recent study, published in Bioorganic & Medicinal Chemistry Letters, explored the anti-inflammatory properties of 3-Bromo-1-methyl-2-phenyl-1H-indole derivatives. The researchers synthesized a series of analogs and evaluated their ability to modulate the NF-κB signaling pathway, a key regulator of inflammatory responses. Several compounds showed promising activity in reducing the production of pro-inflammatory cytokines such as TNF-α and IL-6 in vitro, suggesting their potential as leads for the development of new anti-inflammatory drugs.

From a synthetic chemistry perspective, 3-Bromo-1-methyl-2-phenyl-1H-indole has also been utilized in the development of novel catalytic methodologies. A 2022 report in Organic Letters described its use in palladium-catalyzed C-H activation reactions, enabling the efficient construction of complex heterocyclic scaffolds. This methodology offers a streamlined approach to accessing structurally diverse indole derivatives, which are of great interest in drug discovery due to their prevalence in biologically active molecules.

In addition to its applications in small-molecule drug discovery, 3-Bromo-1-methyl-2-phenyl-1H-indole has been investigated as a potential probe for studying protein-ligand interactions. A recent study in ACS Chemical Biology employed this compound as a starting point for the development of photoaffinity labels, which can be used to identify and characterize binding sites of target proteins. This approach provides valuable insights into the molecular mechanisms underlying the biological activities of indole-based compounds.

Despite these promising developments, challenges remain in optimizing the pharmacokinetic properties of 3-Bromo-1-methyl-2-phenyl-1H-indole derivatives. Recent research has focused on improving their metabolic stability and bioavailability through structural modifications, such as the introduction of fluorine atoms or the incorporation of solubilizing groups. These efforts are critical for advancing these compounds into preclinical and clinical development.

In conclusion, 3-Bromo-1-methyl-2-phenyl-1H-indole (CAS: 609844-40-8) continues to be a valuable scaffold in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate, combined with its diverse biological activities, makes it a promising candidate for the development of new therapeutic agents. Future research should focus on further elucidating its structure-activity relationships and exploring its potential in targeting emerging disease pathways.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)